We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer.
- Authors
Shao, Bin; Liu, Xiaoran; Li, Huiping; Song, Guohong; Di, Lijun; Jiang, Hanfang; Yan, Ying; Zhang, Ruyan; Ran, Ran; Zhang, Jiayang; Liu, Yaxin; Wang, Huan; Wang, Jing
- Abstract
This study aimed to examine the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and other clinicopathological features in HER2+ MBC patients who received first-line anti-HER2 therapy. A total of 129 patients were assigned to NLR-low and NLR-high groups based on a cutoff value of 3.0 at baseline. Peripheral blood lymphocyte subsets and gene mutations in circulating tumor DNA were analyzed by flow cytometry and Next-generation sequencing, respectively. Survival was evaluated by the Kaplan–Meier method and Cox regression analysis. Of the 129 patients, 77 and 52 were assigned to the NLR-low (≤3) and NLR-high (>3) groups, respectively. Compared with NLR-high patients, the NLR-low patients had significantly longer median progression-free survival (PFS) (11.7 vs. 7.7 months) (p = 0.001, HR = 2.703 95% CI 1.543–4.736 and overall survival (OS) (37.4 vs. 28.7 months) (p = 0.044, HR = 2.254 95% CI 1.024–4.924). Furthermore, this association was independent of metastatic sites or estrogen receptor status. Peripheral blood CD3+ (p = 0.034) and CD4+ (p = 0.010) T cell numbers were significantly higher in the NLR-low group than the NLR-high group. The mutational profile of MBC was generally similar between the two groups. Baseline NLR was a prognostic factor of PFS and OS for patients with HER2+ MBC in the first-line setting. These results may facilitate the selection of patients who will benefit most from anti-HER2 treatment.
- Subjects
NEUTROPHILS; LYMPHOCYTES; BREAST metastasis; CANCER prognosis; PROGRESSION-free survival
- Publication
Current Oncology, 2022, Vol 29, Issue 9, p6154
- ISSN
1198-0052
- Publication type
Article
- DOI
10.3390/curroncol29090483